Skip to main content

Find Clinical Trials

Home
Conditions
Fabry Disease

Clinical trial condition

Fabry Disease

Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.

177 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Fabry Disease trial results

Completed

A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease

NCT02930655

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Investigator Site Würzburg, Germany

View Trial Details

Completed

Fabry Screening Study

NCT01019629

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Baylor Institute of Metabolic Disease Dallas, Texas, United States

View Trial Details

Completed

Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease

NCT02995993

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Ruhruniversität Bochum, Klinik für Kinder- und Jugendmedizin im St. Josef-Hospital im Katholischen Klinikum Bochum Bochum, Germany

Universitätsmedizin Mainz, Zentrum für Kinder- und Jugendmedizin Mainz, Germany

View Trial Details

Completed

Screening for Fabry Disease in a Pediatric Population at Risk

NCT02152189

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations: Zentrum für Kinder- und Jugendmedizin Heidelberg, Germany

View Trial Details

Completed

Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function

NCT01730469

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: GSK Investigational Site Costa Mesa, California, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Orlando, Florida, United States

View Trial Details

Completed

Analysis of the Nervous System in Patients With Fabry's Disease

NCT00001491

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity

NCT00106912

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Registry of Fabry Disease - A Multicenter Observational Study

NCT00055016

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Transkaryotic Therapies, Inc. Cambridge, Massachusetts, United States

View Trial Details

Completed

Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta

NCT01745185

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: O&O Alpan Fairfax, Virginia, United States

View Trial Details

Completed

Establishment of Biomarkers for Fabry Disease

NCT01165697

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: Eye and Ear Institute Columbus, Ohio, United States

View Trial Details